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ABSTRACT
Background and Objectives: Transanal minimally inva-
sive surgery (TAMIS) has emerged as an alternative to
transanal endoscopic microsurgery (TEM). The authors
report their experience with TAMIS for the treatment of
mid and high rectal tumors.
Methods: From November 2011 through May 2016, 31
patients (21 females, 68%), with a median age of 65 years
who underwent single-port TAMIS were prospectively
enrolled. Mean distance from the anal verge of the rectal
tumors was 9.5 cm. Seventeen patients presented with T1
cancer, 10 with large adenoma, 2 with gastrointestinal
stromal tumor (GIST) and 2 with carcinoid tumor. Data
concerning demographics, operative procedure and
pathologic results were analyzed.
Results: TAMIS was successfully completed in all cases.
In 4 (13%) TAMIS was converted to standard Park’s
transanal technique. Median postoperative stay was 3
days. The overall complication rate was 9.6%, including
1 urinary tract infection, 1 subcutaneous emphysema,
and 1 hemorrhoidal thrombosis. TAMIS allowed an R0
resection in 96.8% of cases (30/31 cases) and a single
case of local recurrence after a large adenoma resection
was encountered.
Conclusion: TAMIS is a safe technique, with a short
learning curve for laparoscopic surgeons already profi-
cient in single-port procedures, and provides effective
oncological outcomes compared to other techniques.
Key Words: Colorectal surgery, Natural orifice translumi-
nal endoscopic surgery (NOTES) Single-site laparoscopic
surgery (SILS), Surgical oncology, Transanal minimally
invasive Surgery (TAMIS).
INTRODUCTION
Over the past 30 years, significant improvements in
transanal surgery have been reported in an increasing
number of minimally invasive organ-sparing procedures
performed for rectal tumors. In 1983, Buess et al1 intro-
duced the transanal endoscopic microsurgery (TEM) for
the treatment of giant sessile polyps and early rectal can-
cer. Since its introduction, TEM seemed to be a suitable
alternative to the conventional transanal excision (TAE),
showing better outcomes in R0 resection and local recur-
rence rate.2 The technical advantages provided by TEM
instrumentation, as the better exposition, the magnified
3D vision and the operative field illumination allowed the
improved clinical outcomes. Despite this, TEM did not
gained large favor within the surgical community, being
routinely performed in only a few dedicated centers,
mainly because of the long and challenging learning
curve, the high instrumentation costs, and the relative
limited number of patients suitable for the procedure.3
Transanal minimally invasive surgery (TAMIS), since the
first report by Atallah et al,4 has progressively gained
popularity for the treatment of mid and high rectal lesions,
offering a feasible alternative to TEA, TEM, and endo-
scopic submucosal dissection (ESD) in early rectal cancer,
despite the lack of comparative trials. This technique is
performable by a disposable single-port device adapted
for transanal insertion (SILS Port; Covidien, Mansfield,
Massachusetts, USA; and GelPath Transanal Access Plat-
form; Applied Medical, Inc., Rancho Santa Margarita, Cal-
ifornia, USA), and the dissection is performed by standard
laparoscopic instruments.
TAMIS offers several technical advantages compared with
the TEM technique, as the shape of the operative channel
allowing a circumferential dissection without the need to
change patient position and, mainly, the possibility of
using instruments already available in the operative set-
Department of General Surgery; University of Rome “Tor Vergata,” Rome, Italy (all
authors).
All authors contributed to the conception, design of the work; acquisition, analysis,
and interpretation of data; and drafting of the manuscript and revising it critically
for important intellectual content and final approval of the version to be published.
All agreed to be accountable for all aspects of the work in ensuring that questions
related to the accuracy or integrity of any part of the work are appropriately
investigated and resolved.
Address correspondence to: Pierpaolo Sileri, MD, PhD, Assistant Professor of
Surgery, University of Rome “Tor Vergata,” Viale Oxford 81, 00133 Rome, Italy.
Telephone: number: 39 3339137249, Fax: 39.0620902926, E-mail:
piersileri@yahoo.com
DOI: 10.4293/JSLS.2016.00032
© 2016 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. Published by
the Society of Laparoendoscopic Surgeons, Inc.
1July–September 2016 Volume 20 Issue 3 e2016.00032 JSLS www.SLS.org
SCIENTIFIC PAPER
ting. Moreover, the soft transanal access platform is sup-
posed to be safer in postoperative functional outcomes
because of the minor sphincter traction compared to that
in TEM proctoscopy, although incomplete comparative
functional data have been reported.
The purpose of the present study is to investigate TAMIS
technique feasibility and safety in a prospective series of
31 patients with benign and malignant tumors located in
medium and high rectum.
MATERIALS AND METHODS
From November 2009 through May 2016, 31 consecutive
patients with rectal tumors have been treated with single-
port TAMIS. Data collection for all colorectal procedures
was approved by the institutional review board. All pro-
cedures were performed by the same surgical team, ac-
cording to a standardized surgical protocol. Informed con-
sent for the procedure was obtained from all patients.
Data concerning demographics, operative procedure, and
pathologic results were analyzed. Complications were
graded according to the Clavien-Dindo classification.5
Preoperative Evaluation
All patients underwent full colonoscopy with biopsy and
transanal endoscopic ultrasonography. In the case of can-
cer, regional staging was completed by magnetic reso-
nance imaging and computed tomographic (CT) scan.
Patients presenting with suspected lymph nodal involve-
ment or known T2–T3 cancer were excluded from the
study.
Surgical Technique
A full-bowel mechanical preparation was administered
the day before surgery. All patients received preoperative
antibiotics (cephalosporinmetronidazole) and thrombo-
embolic prophylaxis with low-molecular-weight heparin.
In case of peritoneal perforation, antibiotics were contin-
ued for 3 days. All but one patient underwent general
anaesthesia. A single-incision laparoscopic surgery port
(SILS PORT, Covidien) was used in 19 cases and a Gelpath
(Applied Medical Corp.) was used 12 cases performed
since 2015. Surgery was performed with the patient placed
in the Lloyd-Davies position, also in cases of anterior
lesion. After platform insertion, a pneumorectum at 10–12
mmHg was set. Wet gauze was used above the lesion to
reduce cranial colonic distension. Conventional laparo-
scopic instruments were used. A hook-type monopolar
electrocautery or the harmonic scalpel was used for dis-
section and coagulation. After marking the area of resec-
tion, the dissection was started on health tissue 1 cm all
around the lesion margins and carried to obtain a full-
thickness excision. The rectal full-thickness defects were
always closed by interrupted or running barbed sutures
(monofilament 3-0); for this purpose, a pneumorectum
reduction (7–8 mm Hg) is useful to avoid increasing the
tension during suturing. In one case, the lesion was closed
with a GIA universal stapler with a 60-mm purple car-
tridge.
Follow-up and Oncological Outcomes
The patients were examined at 3–6- and 12-month follow-
ups during the first year, then once a year. Endoscopy and
MRI evaluation were performed for the first time 6 months
after surgery and then once a year.
RESULTS
The TAMIS procedure was performed for: (1) T1 adeno-
carcinoma in 17 patients (54.8%), (2) large adenomas in 10
patients (32.2%), (3) GIST in 2 patients (6.5%), and (4)
carcinoid in 2 patients (6.5%). The median age of rectal
tumor patients at the time of surgery was 65 years (range,
36–82) with 21 women (68%) and 10 men (22%). The
mean distance of the lesions from the anal verge was 9.5
cm (range, 6–15 cm), and the mean tumor diameter was
2.4 cm (range, 1–5). Sixteen patients were referred from
other centers and departments after failed endoscopic
resection. TAMIS was successfully completed in all cases,
without the need to conversion to transabdominal sur-
gery. In 2 cases, TAMIS was converted to a standard
transanal technique (6.5%): 1 case of bleeding precluding
the camera view and 1 case of difficult Douglas peritoneal
suture requiring anal Parks dilatators and vaginal valves
for correct exposure.
The abdominal cavity was entered in 5 cases (16.2%), a
suture of a Douglas peritoneal defect was performed with
the TAMIS procedure in 4 cases and by conventional
transanal access in another case, without adverse clinical
consequences. Abdominal cavity entry was more frequent
in upper lesions (distance from the anal verge more than
10 cm) and anterior lesions located 8 cm from the anal
verge. Median postoperative length of stay was 3 days
(range, 2–7).
Complications according to Clavien-Dindo classification5
are listed in Table 1. The overall complication rate was
9.6% (3 patients, and excluding the intraoperative Douglas
peritoneum opening) including 1 urinary tract infection, 1
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subcutaneous emphysema, and 1 hemorrhoidal thrombo-
sis. Urinary infection was treated with oral antibiotics;
subcutaneous emphysema did not require any treatment
and was spontaneously reabsorbed in 4 days. The hem-
orrhoidal thrombosis resolved in 5 days with administra-
tion of a flavonoid drug.
Definitive pathology confirmed the preoperative tumor
histology and staging. TAMIS allowed an R0 resection in
96.8% of cases (30/31 cases). An R1 resection was encoun-
tered in a patient affected by a rectal adenoma (moderated
dysplasia), treated successfully with an endoscopic resec-
tion of residual tumor.
At mean follow-up of 30 months (range, 1–79) there was
1 local recurrence after large adenoma resection 18
months after surgery treated with endoscopic removal of
a 1-cm flat polyp with moderated dysplasia. No cases of
abdominal recurrence related to tumor cell seeding were
recorded in cases of peritoneal entry.
DISCUSSION
TAMIS is a new transanal platform for local excision of
rectal benign and malignant tumors. In past years, TAMIS
has become more popular, and several other studies have
been published, confirming safe and effective results in
early and oncologic outcomes (Table 2).4,6–28 In a recent
4-year review of available clinical data on TAMIS, Martin-
Perez and colleagues,6 reported that early results were
encouraging and that the use of this new approach to
transanal surgery is undergoing significant global growth.
This paper presents a short and preliminary single-center
series of 31 patients affected by medium and high rectal
tumors, including early rectal cancer, treated by TAMIS.
The surgical team had no previous significant experience
with the TEM technique but was recognized as having
substantial laparoscopic single-port device procedure ex-
pertise.
The primary purpose of the study was to establish the
safety of the technique, and the authors found an overall
complication rate of 9.6% (including minor and major
complications) comparable to those reported by the liter-
ature.7–10 None of the complications encountered required
a reoperation or an invasive treatment.
The literature review presented in Table 2, including 513
patients with benign and malignant rectal tumors, dem-
onstrated a 16.8% postoperative complication rate (range,
0–23%).4,7–15,17–28
All the TAMIS procedures presented in this paper have
been completed by the transanal approach and also intra-
operative complications such as bleeding or peritoneal
perforation did not required conversion to an invasive
transabdominal procedure. The data seem to be compa-
rable to those in the literature, presenting a mean 3.1% of
conversion to the laparotomic/laparoscopic approach be-
cause of intraoperative complications.
In the present series, the en bloc resection and R0
resection rates were 100% and 96.8%, respectively, and
these outcomes are comparable to the literature data for
TAMIS technique, describing a 5.6% R1 rate (29/513;
Table 2).4,7–15,17–28
In some institutions, TAMIS is applied in the treatment
of well-selected cases of stage I rectal cancer.11,12 One
argument for this has been the ability to obtain an en
bloc resection with well-defined margins. In a recent
study published by Haugvik and colleagues,13 there
was a high number of positive-resection margins (22%)
in the final pathology specimens. In a systematic review
of 266 TAMIS procedures from 28 studies by Martin-
Perez and colleagues,6 a positive-resection margin was
observed in 5% only, but in almost one-third (31%) of
the surgical specimens, the microscopic resection status
could not be defined because of frequent tissue frag-
mentation.6
Table 1.
Complications According to Clavien Classification 5
Complications
Number of
Patients (%) Treatment
Clavien-Dindo
Classification
Peritoneum perforation during surgery 5 (16.2) Intraoperative suture NC
Urinary tract infection 1 (3.2) Antibiotics II
Subcutaneous emphysema 1 (3.2) None I
Hemorrhoid thrombosis 1 (3.2) Flavonods drugs II
NC, not classified.
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Highlighting the advantages of the TAMIS procedure,
Haugvik et al13 demonstrated that one-third of the speci-
mens were upgraded on final histology when compared
with preoperative biopsies. This outcome indicates an
advantage of TAMIS in optimal specimen quality for his-
tologic analysis of large rectal polyps, compared with
conventional piecemeal endoscopic mucosal resection,
where resection margins are undefined and en bloc re-
sections are lacking.
Standardization of the technique should be considered the
primary outcome at the beginning of the learning curve,
even if surgery is performed by an experienced laparo-
scopic surgeon. The first aspect to evaluate is the lesion
distance from the anal verge, many authors indicated an
ideal range from 6 to 10 cm.14,15 In this condition, the
instruments manoeuvrability and the vision are optimal
for the dissection independently from the anatomical le-
sion location.
The best method for closure of the rectal wall defect after
a full-thickness excision is still debated. A recent multi-
center trial published by Hahnloser et al9 comparing mor-
bidity and incontinence rates between patients undergo-
Table 2.
Published TAMIS Series With at Least 5 Patients
Authors Year Device
Pts
(n) B:M:O*
Conversion
(n)
Complications
(n)
R1
(n) LR† (%)
Follow up
(months)
Atallah et al4 2010 SILS‡ 6 3:2:1 0 0 1 NA 1.5
Cid et al11 2010 SILS 5 4:1:0 0 0 NA NA 3
Van den Boezem
et al21
2011 SILS 12 9:3:0 2 2 0 NA NA
Lorenz et al22 2011 SILS/TriPort 13 0:13:0 0 0 — NA 0.5
Carrara et al17 2012 Glove 8 5:3:0 0 0 0 NA 5
Lim et al12 2012 SILS 16 0:11:5 0 0 0 NA 3
Hompes et al23 2012 Glove 14 7:6:1 2 2 2 1 5.7
Ragupathi et al14 2012 SILS 20 14:6:0 0 1 1 1 NA
Canda et al24 2012 SILS 6 5:1:0 0 0 0 NA 3.8
Cantero and
Delgado25
2012 SILS 20 0:20:0 0 0 NA NA NA
Barendse et al26 2012 SSL‡ 15 9:4:2 2 2 0 NA NA
Albert et al15 2013 SILS/GelPath 50 25:23:2 0 4 3 2 20
Lee and Lee19 2013 SILS 25 6:9:10 0 1 0 0 9.8
Gorgun et al10 2013 GelPath 12 10:1:1 2 3 NA NA NA
Mendes et al20 2013 SSL‡ 11 4:2:5 0 1 0 0 9.2
Bridoux et al27 2013 Endorectal
trocar
14 10:4:0 0 3 1 1 NA
McLemore8 2014 SILS/GelPath 32 13:16:3 3 (Leak test) 5 0 0 3–23
Hahnloser et al9 2014 SILS 75 25:49:1 3 (Peritoneal
suture)
23 3 NA NA
Gill et al7 2015 GelPath 32 11:16:5 0 16 0 1 distant NA
Sumrien et al28 2016 SILS/GelPath 28 17:11:0 2 7 6 2 NA
Haugvik et al13 2016 SILS/GelPath 51 43:8:0 0 6 11 0 48
Verseveld et al18 2016 SSL 24 4:20:0 0 1 0 0 NA
Present series 2016 SILS/GelPath 31 10:17:4 0 8 1 1 30
TOTAL — — 513 233:240:40 16 (3.11%) 85 (16.5%) 29 (5.6%) 8 (1.5%) —
*Ratio benign:malignant:other; †local recurrence; ‡single-site laparoscopic port.
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ing the suture of the rectum or a left-open technique,
failed to demonstrate any significant differences between
the 2 groups of patients. In the present series all the
defects were surgically closed, with the intent to improve
the learning curve in suturing during transanal single-port
surgery.
No comparative clinical studies or randomized control
trials are available to establish the equivalence or the
superiority of TAMIS to the TEM procedure, although a
preliminary evaluation on a phantom model has been
published by Rimonda and colleagues.16 In this study,
several surgeons were asked to perform a rectal lesion
excision by the TEM and TAMIS procedures in a phantom
model with the intent to evaluate the difficulty of dissec-
tion and suture and the quality of the vision and the
conflict between the instruments. TEM results were supe-
rior to those of TAMIS in all the investigated items. How-
ever, these data are in contrast to the relatively rapid
spread of the use of TAMIS in clinical practice, espe-
cially among colorectal surgeons who do not routinely
performed TEM.14,15,17 Moreover, some authors with
experience in TEM surgery have started to publish
TAMIS surgery reports with encouraging data on func-
tional results.18
CONCLUSIONS
Despite the encouraging technical and preliminary onco-
logical outcomes obtained by the TAMIS procedure, short-
term follow-up data8,15,19,20 are not yet able to establish its
equivalence to the TEM procedure in long-term oncolog-
ical outcomes. Further multicenter prospective random-
ized studies are needed.
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